Answer
Nubeqa (darolutamide) is contraindicated in people with hypersensitivity to darolutamide or any excipient listed in section 6.1, and in women who are or may become pregnant.
Sources for this answer
- NUBEQA 300 mg film coated tabletsBayer plc · emc · SmPC §4.3 Contraindications · Version 11Document updated
Sources checked